Report Detail

Request for Sample of this report

Pharma & Healthcare Global Leukotriene Antagonists Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4677384
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 141 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Leukotriene Antagonists market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Leukotriene Antagonists market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Leukotriene Antagonists market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Leukotriene Antagonists market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Leukotriene Antagonists market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Leukotriene Antagonists market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Leukotriene Antagonists
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Leukotriene Antagonists market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Morepen Laboratories Ltd., Dr. Reddy's, Vamsi Labs, Shandong Octagon Chemicals Limited, Xi'an ZB Biotech Co., Ltd, Unimark Remedies, Miat, Teva API, Tianyu Pharm, Laurus Labs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Leukotriene Antagonists market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Leukotriene Receptor Antagonists
Leukotriene Synthesis Inhibitor
Market segment by Application
Hospital
Pharmacy
Clinic
Major players covered
Morepen Laboratories Ltd.
Dr. Reddy's
Vamsi Labs
Shandong Octagon Chemicals Limited
Xi'an ZB Biotech Co., Ltd
Unimark Remedies
Miat
Teva API
Tianyu Pharm
Laurus Labs
Inke S.A.
Hwail Pharm
Unichem Labs.
JW Pharmaceutical
Qilu Tianhe
Triquim
Formosa Labs
Sintenovo
Torrent Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Leukotriene Antagonists product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Leukotriene Antagonists, with price, sales quantity, revenue, and global market share of Leukotriene Antagonists from 2021 to 2026.
Chapter 3, the Leukotriene Antagonists competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leukotriene Antagonists breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Leukotriene Antagonists market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Leukotriene Antagonists.
Chapter 14 and 15, to describe Leukotriene Antagonists sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Leukotriene Antagonists Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Leukotriene Receptor Antagonists
    • 1.3.3 Leukotriene Synthesis Inhibitor
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Leukotriene Antagonists Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
    • 1.4.4 Clinic
  • 1.5 Global Leukotriene Antagonists Market Size & Forecast
    • 1.5.1 Global Leukotriene Antagonists Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Leukotriene Antagonists Sales Quantity (2021-2032)
    • 1.5.3 Global Leukotriene Antagonists Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Morepen Laboratories Ltd.
    • 2.1.1 Morepen Laboratories Ltd. Details
    • 2.1.2 Morepen Laboratories Ltd. Major Business
    • 2.1.3 Morepen Laboratories Ltd. Leukotriene Antagonists Product and Services
    • 2.1.4 Morepen Laboratories Ltd. Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Morepen Laboratories Ltd. Recent Developments/Updates
  • 2.2 Dr. Reddy's
    • 2.2.1 Dr. Reddy's Details
    • 2.2.2 Dr. Reddy's Major Business
    • 2.2.3 Dr. Reddy's Leukotriene Antagonists Product and Services
    • 2.2.4 Dr. Reddy's Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Dr. Reddy's Recent Developments/Updates
  • 2.3 Vamsi Labs
    • 2.3.1 Vamsi Labs Details
    • 2.3.2 Vamsi Labs Major Business
    • 2.3.3 Vamsi Labs Leukotriene Antagonists Product and Services
    • 2.3.4 Vamsi Labs Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Vamsi Labs Recent Developments/Updates
  • 2.4 Shandong Octagon Chemicals Limited
    • 2.4.1 Shandong Octagon Chemicals Limited Details
    • 2.4.2 Shandong Octagon Chemicals Limited Major Business
    • 2.4.3 Shandong Octagon Chemicals Limited Leukotriene Antagonists Product and Services
    • 2.4.4 Shandong Octagon Chemicals Limited Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shandong Octagon Chemicals Limited Recent Developments/Updates
  • 2.5 Xi'an ZB Biotech Co., Ltd
    • 2.5.1 Xi'an ZB Biotech Co., Ltd Details
    • 2.5.2 Xi'an ZB Biotech Co., Ltd Major Business
    • 2.5.3 Xi'an ZB Biotech Co., Ltd Leukotriene Antagonists Product and Services
    • 2.5.4 Xi'an ZB Biotech Co., Ltd Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Xi'an ZB Biotech Co., Ltd Recent Developments/Updates
  • 2.6 Unimark Remedies
    • 2.6.1 Unimark Remedies Details
    • 2.6.2 Unimark Remedies Major Business
    • 2.6.3 Unimark Remedies Leukotriene Antagonists Product and Services
    • 2.6.4 Unimark Remedies Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Unimark Remedies Recent Developments/Updates
  • 2.7 Miat
    • 2.7.1 Miat Details
    • 2.7.2 Miat Major Business
    • 2.7.3 Miat Leukotriene Antagonists Product and Services
    • 2.7.4 Miat Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Miat Recent Developments/Updates
  • 2.8 Teva API
    • 2.8.1 Teva API Details
    • 2.8.2 Teva API Major Business
    • 2.8.3 Teva API Leukotriene Antagonists Product and Services
    • 2.8.4 Teva API Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Teva API Recent Developments/Updates
  • 2.9 Tianyu Pharm
    • 2.9.1 Tianyu Pharm Details
    • 2.9.2 Tianyu Pharm Major Business
    • 2.9.3 Tianyu Pharm Leukotriene Antagonists Product and Services
    • 2.9.4 Tianyu Pharm Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Tianyu Pharm Recent Developments/Updates
  • 2.10 Laurus Labs
    • 2.10.1 Laurus Labs Details
    • 2.10.2 Laurus Labs Major Business
    • 2.10.3 Laurus Labs Leukotriene Antagonists Product and Services
    • 2.10.4 Laurus Labs Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Laurus Labs Recent Developments/Updates
  • 2.11 Inke S.A.
    • 2.11.1 Inke S.A. Details
    • 2.11.2 Inke S.A. Major Business
    • 2.11.3 Inke S.A. Leukotriene Antagonists Product and Services
    • 2.11.4 Inke S.A. Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Inke S.A. Recent Developments/Updates
  • 2.12 Hwail Pharm
    • 2.12.1 Hwail Pharm Details
    • 2.12.2 Hwail Pharm Major Business
    • 2.12.3 Hwail Pharm Leukotriene Antagonists Product and Services
    • 2.12.4 Hwail Pharm Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hwail Pharm Recent Developments/Updates
  • 2.13 Unichem Labs.
    • 2.13.1 Unichem Labs. Details
    • 2.13.2 Unichem Labs. Major Business
    • 2.13.3 Unichem Labs. Leukotriene Antagonists Product and Services
    • 2.13.4 Unichem Labs. Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Unichem Labs. Recent Developments/Updates
  • 2.14 JW Pharmaceutical
    • 2.14.1 JW Pharmaceutical Details
    • 2.14.2 JW Pharmaceutical Major Business
    • 2.14.3 JW Pharmaceutical Leukotriene Antagonists Product and Services
    • 2.14.4 JW Pharmaceutical Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 JW Pharmaceutical Recent Developments/Updates
  • 2.15 Qilu Tianhe
    • 2.15.1 Qilu Tianhe Details
    • 2.15.2 Qilu Tianhe Major Business
    • 2.15.3 Qilu Tianhe Leukotriene Antagonists Product and Services
    • 2.15.4 Qilu Tianhe Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Qilu Tianhe Recent Developments/Updates
  • 2.16 Triquim
    • 2.16.1 Triquim Details
    • 2.16.2 Triquim Major Business
    • 2.16.3 Triquim Leukotriene Antagonists Product and Services
    • 2.16.4 Triquim Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Triquim Recent Developments/Updates
  • 2.17 Formosa Labs
    • 2.17.1 Formosa Labs Details
    • 2.17.2 Formosa Labs Major Business
    • 2.17.3 Formosa Labs Leukotriene Antagonists Product and Services
    • 2.17.4 Formosa Labs Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Formosa Labs Recent Developments/Updates
  • 2.18 Sintenovo
    • 2.18.1 Sintenovo Details
    • 2.18.2 Sintenovo Major Business
    • 2.18.3 Sintenovo Leukotriene Antagonists Product and Services
    • 2.18.4 Sintenovo Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Sintenovo Recent Developments/Updates
  • 2.19 Torrent Pharma
    • 2.19.1 Torrent Pharma Details
    • 2.19.2 Torrent Pharma Major Business
    • 2.19.3 Torrent Pharma Leukotriene Antagonists Product and Services
    • 2.19.4 Torrent Pharma Leukotriene Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Torrent Pharma Recent Developments/Updates

3 Competitive Environment: Leukotriene Antagonists by Manufacturer

  • 3.1 Global Leukotriene Antagonists Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Leukotriene Antagonists Revenue by Manufacturer (2021-2026)
  • 3.3 Global Leukotriene Antagonists Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Leukotriene Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Leukotriene Antagonists Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Leukotriene Antagonists Manufacturer Market Share in 2025
  • 3.5 Leukotriene Antagonists Market: Overall Company Footprint Analysis
    • 3.5.1 Leukotriene Antagonists Market: Region Footprint
    • 3.5.2 Leukotriene Antagonists Market: Company Product Type Footprint
    • 3.5.3 Leukotriene Antagonists Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Leukotriene Antagonists Market Size by Region
    • 4.1.1 Global Leukotriene Antagonists Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Leukotriene Antagonists Consumption Value by Region (2021-2032)
    • 4.1.3 Global Leukotriene Antagonists Average Price by Region (2021-2032)
  • 4.2 North America Leukotriene Antagonists Consumption Value (2021-2032)
  • 4.3 Europe Leukotriene Antagonists Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Leukotriene Antagonists Consumption Value (2021-2032)
  • 4.5 South America Leukotriene Antagonists Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Leukotriene Antagonists Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 5.2 Global Leukotriene Antagonists Consumption Value by Type (2021-2032)
  • 5.3 Global Leukotriene Antagonists Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 6.2 Global Leukotriene Antagonists Consumption Value by Application (2021-2032)
  • 6.3 Global Leukotriene Antagonists Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 7.2 North America Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 7.3 North America Leukotriene Antagonists Market Size by Country
    • 7.3.1 North America Leukotriene Antagonists Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Leukotriene Antagonists Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 8.2 Europe Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 8.3 Europe Leukotriene Antagonists Market Size by Country
    • 8.3.1 Europe Leukotriene Antagonists Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Leukotriene Antagonists Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Leukotriene Antagonists Market Size by Region
    • 9.3.1 Asia-Pacific Leukotriene Antagonists Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Leukotriene Antagonists Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 10.2 South America Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 10.3 South America Leukotriene Antagonists Market Size by Country
    • 10.3.1 South America Leukotriene Antagonists Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Leukotriene Antagonists Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Leukotriene Antagonists Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Leukotriene Antagonists Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Leukotriene Antagonists Market Size by Country
    • 11.3.1 Middle East & Africa Leukotriene Antagonists Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Leukotriene Antagonists Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Leukotriene Antagonists Market Drivers
  • 12.2 Leukotriene Antagonists Market Restraints
  • 12.3 Leukotriene Antagonists Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Leukotriene Antagonists and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Leukotriene Antagonists
  • 13.3 Leukotriene Antagonists Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Leukotriene Antagonists Typical Distributors
  • 14.3 Leukotriene Antagonists Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Leukotriene Antagonists. Industry analysis & Market Report on Leukotriene Antagonists is a syndicated market report, published as Global Leukotriene Antagonists Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Leukotriene Antagonists market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo